TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.
To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.
| Disease | Cross reference | Weighted score | Related literature |
|---|
We collected disease MeSH terms mapped to the references associated with TRIPALMITIN
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Leishmaniasis, Visceral | D007898 | 13 associated lipids |
| Respiratory Distress Syndrome, Newborn | D012127 | 5 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Malabsorption Syndromes | D008286 | 16 associated lipids |
| HIV-Associated Lipodystrophy Syndrome | D039682 | 3 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
| Gene | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Greiner M et al. | Temperature- and pressure-dependent densities, self-diffusion coefficients, and phase behavior of monoacid saturated triacylglycerides: toward molecular-level insights into processing. | 2012 | J. Agric. Food Chem. | pmid:22500590 |
| Teichert SA and Akoh CC | Characterization of stearidonic acid soybean oil enriched with palmitic acid produced by solvent-free enzymatic interesterification. | 2011 | J. Agric. Food Chem. | pmid:21830790 |
| Teichert SA and Akoh CC | Modifications of stearidonic acid soybean oil by enzymatic acidolysis for the production of human milk fat analogues. | 2011 | J. Agric. Food Chem. | pmid:22097918 |
| Hall A et al. | Modeling of the triglyceride-rich core in lipoprotein particles. | 2008 | J Phys Chem B | pmid:18844397 |
| Schmiele M et al. | Mesoscopic structures of triglyceride nanosuspensions studied by small-angle X-ray and neutron scattering and computer simulations. | 2014 | J Phys Chem B | pmid:24950992 |
| Hitzman CJ et al. | Development of a respirable, sustained release microcarrier for 5-fluorouracil II: In vitro and in vivo optimization of lipid coated nanoparticles. | 2006 | J Pharm Sci | pmid:16570303 |
| Windbergs M et al. | Investigating the relationship between drug distribution in solid lipid matrices and dissolution behaviour using Raman spectroscopy and mapping. | 2010 | J Pharm Sci | pmid:19691104 |
| Stocker E et al. | Application of ICH Q9 Quality Risk Management Tools for Advanced Development of Hot Melt Coated Multiparticulate Systems. | 2017 | J Pharm Sci | pmid:27842971 |
| Haaser M et al. | Analysis of matrix dosage forms during dissolution testing using raman microscopy. | 2011 | J Pharm Sci | pmid:21560128 |
| Tursilli R et al. | Enhancement of melatonin photostability by encapsulation in lipospheres. | 2006 | J Pharm Biomed Anal | pmid:16242283 |
| Mihara H et al. | [Effect of crystallization temperature of palm oil on its crystallization. IV. The influence of tripalmitoylglycerol (PPP) on the crystallization of 1,3-dipalmitoyl-2-oleoyl-glycerol (POP) and 1,2-dioleoyl-3-palmitoyl-glycerol (POO)]. | 2007 | J Oleo Sci | pmid:17898485 |
| Yoshikawa S et al. | Promotional effects of new types of additives on fat crystallization. | 2014 | J Oleo Sci | pmid:24599107 |
| Aramaki K et al. | Preparation of O/I1-type Emulsions and S/I1-type Dispersions Encapsulating UV-Absorbing Agents. | 2015 | J Oleo Sci | pmid:26178999 |
| Ucisik MH et al. | Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. | 2013 | J Nanobiotechnology | pmid:24314310 |
| Potta SG et al. | Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility. | 2011 | J Microencapsul | pmid:21171818 |
| Pal A et al. | Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis. | 2012 | J Liposome Res | pmid:21740098 |
| Manjunath K and Venkateswarlu V | Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. | 2006 | J Drug Target | pmid:17090399 |
| Severino P et al. | Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. | 2012 | J Drug Deliv | pmid:22175030 |
| Vitorino C et al. | Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. | 2013 | J Control Release | pmid:23454133 |
| Venkateswarlu V and Manjunath K | Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. | 2004 | J Control Release | pmid:15023472 |